NIAGARA in the EV + IO Era

NIAGARA in the EV + IO Era

Medical professionals Dr. Raji Shameem, Dr. David H. Aggen, Dr. Alexandra Drakaki, and Dr. Ashish M. Kamat discuss personalized perioperative treatment for MIBC with NIAGARA and EV-based regimens.

NIAGARA in the EV + IO Era

07/31/2026

Ep. 4: Personalizing Perioperative Treatment for Muscle-Invasive Bladder Cancer With NIAGARA and EV-Based Regimens

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Medical professionals discussing perioperative therapy for MIBC based on patient and tumor characteristics in a hospital setting.

NIAGARA in the EV + IO Era

07/30/2026

Ep. 3: Selecting Perioperative Therapy for Muscle-Invasive Bladder Cancer Based on Patient and Tumor Characteristics

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Medical professionals discussing perioperative MIBC interpreting pCR, survival, and treatment options in a hospital setting.

NIAGARA in the EV + IO Era

07/26/2026

Ep. 2: Perioperative Muscle-Invasive Bladder Cancer: Interpreting pCR, Survival, and Treatment Selection

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Panel discussion on NIAGARA and EV-Based Perioperative Therapy Reshaping MIBC Treatment with Dr. Raji Shameem, Dr. David H. Aggen, Dr. Alexandra Drakaki, and Dr. Ashish M. Kamat.

NIAGARA in the EV + IO Era

07/24/2026

Ep. 1: NIAGARA and EV-Based Perioperative Therapy Reshape Treatment for Muscle-Invasive Bladder Cancer

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Medical professionals discussing redefining perioperative bladder cancer treatment with NIAGARA in the EV + IO era.

NIAGARA in the EV + IO Era

07/23/2026

Experts Review Perioperative Regimens and Potential Future Strategies for Resectable MIBC

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD